Anderson KC - Search Results

1

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Schiffer CA, Bohlke K, Anderson KC. Schiffer CA, et al. Among authors: anderson kc. J Oncol Pract. 2018 Feb;14(2):129-133. doi: 10.1200/JOP.2017.028902. Epub 2017 Nov 28. J Oncol Pract. 2018. PMID: 29182492 No abstract available.

2

What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?

Benjamin RJ, Anderson KC. Benjamin RJ, et al. Among authors: anderson kc. Crit Rev Oncol Hematol. 2002 May;42(2):163-71. doi: 10.1016/s1040-8428(01)00182-2. Crit Rev Oncol Hematol. 2002. PMID: 12007974 Review.

3

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, Biermann JS; American Society of Clinical Oncology Bisphosphonates Expert Panel. Berenson JR, et al. J Clin Oncol. 2002 Sep 1;20(17):3719-36. doi: 10.1200/JCO.2002.06.037. J Clin Oncol. 2002. PMID: 12202673

4

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Schiffer CA, Bohlke K, Delaney M, Hume H, Magdalinski AJ, McCullough JJ, Omel JL, Rainey JM, Rebulla P, Rowley SD, Troner MB, Anderson KC. Schiffer CA, et al. Among authors: anderson kc. J Clin Oncol. 2018 Jan 20;36(3):283-299. doi: 10.1200/JCO.2017.76.1734. Epub 2017 Nov 28. J Clin Oncol. 2018. PMID: 29182495

5

Promise of Immune Therapies in Multiple Myeloma.

Anderson KC. Anderson KC. J Oncol Pract. 2018 Jul;14(7):411-413. doi: 10.1200/JOP.18.00311. J Oncol Pract. 2018. PMID: 29996072 Free PMC article. No abstract available.

6

Clinical update: novel targets in multiple myeloma.

Anderson KC. Anderson KC. Semin Oncol. 2004 Dec;31(6 Suppl 16):27-32; discussion 33. doi: 10.1053/j.seminoncol.2004.10.016. Semin Oncol. 2004. PMID: 15799242 Review.

7

Can thalidomide improve outcome in patients with multiple myeloma?

Richardson PG, Mitsiades CS, Munshi NC, Anderson KC. Richardson PG, et al. Among authors: anderson kc. Nat Clin Pract Oncol. 2006 Nov;3(11):590-1. doi: 10.1038/ncponc0630. Nat Clin Pract Oncol. 2006. PMID: 17080171 No abstract available.

8

New drugs for multiple myeloma.

Anderson KC. Anderson KC. Clin Adv Hematol Oncol. 2006 Aug;4(8):592-4. Clin Adv Hematol Oncol. 2006. PMID: 17099617 No abstract available.

9

Does maintenance therapy with thalidomide benefit patients with multiple myeloma?

Munshi NC, Mitsiades CS, Richardson PG, Anderson KC. Munshi NC, et al. Among authors: anderson kc. Nat Clin Pract Oncol. 2007 Jul;4(7):394-5. doi: 10.1038/ncponc0847. Epub 2007 May 29. Nat Clin Pract Oncol. 2007. PMID: 17534287 No abstract available.

10

Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma.

Munshi NC, Mitsiades C, Richardson PG, Anderson KC. Munshi NC, et al. Among authors: anderson kc. Nat Clin Pract Oncol. 2008 Jul;5(7):374-5. doi: 10.1038/ncponc1151. Epub 2008 Jun 10. Nat Clin Pract Oncol. 2008. PMID: 18542118 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,201 results

Search Page